계명대학교 의학도서관 Repository

2020 Korean guidelines for the management of metastatic prostate cancer

Metadata Downloads
Author(s)
In-Ho KimSang Joon ShinByung Woog KangJihoon KangDalyong KimMiso KimJin Young KimChan Kyu KimHee-Jun KimChi Hoon MaengKwonoh ParkInkeun ParkWoo Kyun BaeByeong Seok SohnMin-Young LeeJae Lyun LeeJunglim LeeSeung Taek LimJoo Han LimHyun ChangJoo Young JungYoon Ji ChoiYoung Seok KimJaeho ChoJae Young JoungSe Hoon ParkHyo Jin Lee
Keimyung Author(s)
Kim, Jin Young
Department
Dept. of Internal Medicine (내과학)
Journal Title
Korean J Intern Med
Issued Date
2021
Volume
36
Issue
3
Keyword
Practice guidelineProstate neoplasms
Abstract
In 2017, Korean Society of Medical Oncology (KSMO) published the Korean management guideline of metastatic prostate cancer. This paper is the 2nd edition of the Korean management guideline of metastatic prostate cancer. We updated recent many changes of management in metastatic prostate cancer in this 2nd edition guideline. The present guideline consists of the three categories: management of metastatic hormone sensitive prostate cancer; management of metastatic castration resistant prostate cancer; and clinical consideration for treating patients with metastatic prostate cancer. In category 1 and 2, levels of evidence (LEs) have been mentioned according to the general principles of evidence-based medicine. And grades of recommendation (GR) was taken into account the quality of evidence, the balance between desirable and undesirable effects, the values and preferences, and the use of resources and GR were divided into strong recommendations (SR) and weak recommendations (WR). A total of 16 key questions are selected. And we proposed recommendations and described key evidence for each recommendation. The treatment landscape of metastatic prostate cancer is changing very rapid and many trials are ongoing. To verify the results of the future trials is necessary and should be applied to the treatment for metastatic prostate cancer patients in the clinical practice. Especially, many prostate cancer patients are old age, have multiple underlying medical comorbidities, clinicians should be aware of the significance of medical management as well as clinical efficacy of systemic treatment.
Keimyung Author(s)(Kor)
김진영
Publisher
School of Medicine (의과대학)
Citation
In-Ho Kim et al. (2021). 2020 Korean guidelines for the management of metastatic prostate cancer. Korean J Intern Med, 36(3), 491–514. doi: 10.3904/kjim.2020.213
Type
Article
ISSN
2005-6648
Source
https://www.kjim.org/journal/view.php?doi=10.3904/kjim.2020.213
DOI
10.3904/kjim.2020.213
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/43633
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
Authorize & License
  • Authorize공개
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.